In this study TCF3::PBX1-positive ALL showed better DFS than KMT2A::AFF1- and BCR::ABL1p190−positive ALL, suggesting that the current treatment protocols used in Mexico show improvements in early mortality. The gene discussed is AFF1; the disease is acute lymphoblastic leukemia.